These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 20205992)
21. Management and monitoring of patients treated with zonisamide: the OZONE study. Dupont S; Biraben A; Lavernhe G; Marquet T; Allaf B Epileptic Disord; 2013 Sep; 15(3):278-88. PubMed ID: 23906691 [TBL] [Abstract][Full Text] [Related]
22. [Zonisamide in the epilepsy treatment: a literature review from add-on therapy to monotherapy]. Villanueva V; Serrano-Castro PJ Rev Neurol; 2013 Apr; 56(8):429-38. PubMed ID: 23568686 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Johannessen SI; Tomson T Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of zonisamide: results of a multicenter study. Leppik IE; Willmore LJ; Homan RW; Fromm G; Oommen KJ; Penry JK; Sackellares JC; Smith DB; Lesser RP; Wallace JD Epilepsy Res; 1993 Feb; 14(2):165-73. PubMed ID: 8453952 [TBL] [Abstract][Full Text] [Related]
26. Two nursing mothers treated with zonisamide: Should breast-feeding be avoided? Ando H; Matsubara S; Oi A; Usui R; Suzuki M; Fujimura A J Obstet Gynaecol Res; 2014 Jan; 40(1):275-8. PubMed ID: 24033821 [TBL] [Abstract][Full Text] [Related]
27. Influence of coadministered antiepileptic drugs on serum zonisamide concentrations in epileptic patients: quantitative analysis based on suitable transforming factor. Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S Biol Pharm Bull; 2003 Dec; 26(12):1734-8. PubMed ID: 14646181 [TBL] [Abstract][Full Text] [Related]
28. Zonisamide. Seino M; Miyazaki H; Ito T Epilepsy Res Suppl; 1991; 3():169-74. PubMed ID: 1777076 [No Abstract] [Full Text] [Related]
29. Zonisamide monotherapy for epilepsy in children and young adults. Wilfong AA Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764 [TBL] [Abstract][Full Text] [Related]
30. Zonisamide: a review of its use in the management of adults with partial seizures. Hoy SM Drugs; 2013 Aug; 73(12):1321-38. PubMed ID: 23873520 [TBL] [Abstract][Full Text] [Related]
31. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy. Wroe SJ; Yeates AB; Marshall A Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272 [TBL] [Abstract][Full Text] [Related]
32. Zonisamide in the management of epilepsy in the elderly. Romigi A; Femia EA; Fattore C; Vitrani G; Di Gennaro G; Franco V Clin Interv Aging; 2015; 10():931-7. PubMed ID: 26089654 [TBL] [Abstract][Full Text] [Related]
33. Zonisamide in the treatment of epilepsy. Holder JL; Wilfong AA Expert Opin Pharmacother; 2011 Nov; 12(16):2573-81. PubMed ID: 21967409 [TBL] [Abstract][Full Text] [Related]
34. Zonisamide (Zonegran) for epilepsy. Med Lett Drugs Ther; 2000 Oct; 42(1089):94-5. PubMed ID: 11015160 [No Abstract] [Full Text] [Related]
35. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. Baulac M; Leppik IE Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670 [TBL] [Abstract][Full Text] [Related]
36. Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults. Mula M Drug Des Devel Ther; 2013; 7():397-402. PubMed ID: 23700365 [TBL] [Abstract][Full Text] [Related]
37. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Shinnar S; Pellock JM; Conry JA Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174 [TBL] [Abstract][Full Text] [Related]
38. An assessment of zonisamide as an anti-epileptic drug. Jain KK Expert Opin Pharmacother; 2000 Sep; 1(6):1245-60. PubMed ID: 11249491 [TBL] [Abstract][Full Text] [Related]